second generation red cell-derived microparticles (RxMP Therapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesecond generation red cell-derived microparticles (RxMP Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBlood coagulation stimulants
TargetsUpdating
Therapy Area/IndicationsHemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRxMP Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRxMP Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHemorrhage

Other Information

ATC CodeN/A
Related LinksN/A